09:39 AM EST - Knight Therapeutics Inc. : Reported financial results for its second quarter ended June 30, 2022. Revenues were $75,820, an increase of $10,024 or 15% over the same period in prior year. Net loss on financial assets measured at fair value through profit or loss of $7,692. Knight Therapeutics Inc.
shares T.GUD are trading unchanged at $5.56.
